DAISY PHARMA OPIOID VENTURE, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Dronabinol Opioid Sparing Evaluation (DOSE) Trial

Phase 2

Conditions: Chronic Pain

Interventions: Drug: Dronabinol

First Posted Date: 2018-12-06

Last Posted Date: 2018-12-06

Lead Sponsor: Daisy Pharma Opioid Venture, LLC

Target Recruit Count: 280

Registration Number: NCT03766269

Locations: 🇺🇸
Daisy Research, Inc., Scottsdale, Arizona, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy